EMV Capital is an award-winning VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors in the UK and internationally. EMV Capital develops unique investment strategies for each portfolio company, drawing on its EIS fund and extensive network of private investors, family offices, institutions, and corporate VCs. Delivery and successful execution of these investment strategies enables innovative portfolio companies to raise funding to drive transformational growth. EMV Capital is a wholly owned subsidiary of NetScientific plc (AIM:NSCI), a life sciences and technology commercialisation and investment group.
Location: United Kingdom, England, City of London
Employees: 11-50
Founded date: 2018
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 15.06.2022 | Q-Bot Ltd | q-bot.co | $10.14M | United Kin... |
| 20.05.2021 | PointGrab | pointgrab.com | $16.81M | Israel, Ce... |
| 28.04.2021 | Sofant Tec... | sofant.com | $18M | United Kin... |
Mentions in press and media 19
| Date | Title | Description |
| 11.11.2024 | EpiBone: Pioneering the Future of Skeletal Repair | EpiBone is on a mission. This New York City-based company is not just another name in the crowded field of regenerative medicine. It’s a beacon of hope for those suffering from skeletal injuries and diseases. Recently, EpiBone secured a sig... |
| 11.11.2024 | EpiBone Raises Funding Round | EpiBone, a NYC-based regenerative medicine company, raised an undisclosed amount in funding. The round was led by Kendall Capital Partners, with participation from LifeSpan Vision Ventures, EMV Capital, and others. The company intends to us... |
| 08.11.2024 | EpiBone: Regenerative Medicine Company Raises Funding | EpiBone – a leading regenerative medicine company focused on skeletal repair – announced the closing of a convertible note funding round led by Kendall Capital Partners, with participation from LifeSpan Vision Ventures, EMV Capital, and oth... |
| 05.06.2024 | Edinburgh-based Sofant Technologies Raises Additional £3.4M | Edinburgh-based wireless tech specialists, Sofant Technologies, has successfully raised £3.4 million in additional funding. The investment, which has come from Scottish Enterprise, Kelvin Capital, and EMV Capital, is to be used to complete ... |
| 14.05.2024 | Deeptech investor EMV Capital acquires Martlet Capital | Deeptech investment firm EMV Capital has acquired the Cambridge-based seed-stage VC Martlet Capital, excluding its investment portfolio. EMV Capital will manage, on a discretionary basis, Martlet Capital’s £23.3M portfolio of investments ac... |
| 29.11.2022 | Edinburgh's Sofant Technologies raises £4.2 million for its next-gen satellite and 5G antennae | UK-based smart antenna developer Sofant Technologies has just raised a £4.2 million round, and says it's garnering market traction following its first major contract signing with an unnamed defence contractor. The University of Edinburgh sp... |
| 16.08.2022 | EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth. | EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth. Tue, Aug 16, 2022 17:04 CET Report this content London, UK, 16th August 2022 – International venture capital in... |
| 15.06.2022 | EMV Capital leads a £1.6m investment into Q-Bot Ltd | EMV Capital leads a £1.6m investment into Q-Bot Ltd Wed, Jun 15, 2022 11:14 CET Report this content EMV Capital announces that it has led a £1.6m investment into Q-Bot Ltd, the UK’s leading developer of robotics in the construction retrofit... |
| 17.12.2021 | Bureau Unveils Secure Transactions for Global Emerging Markets with Easy ID Verification and Guaranteed Fraud Protection | “We are excited to see Bureau’s growth and ambition to become the gold standard to ensure that people and businesses can truly trust one another enough to transact safely, and deliver digital and financial inclusion.” SAN FRANCISCO and BANG... |
| 26.11.2021 | NetScientific : $1million investment in portfolio company, EpiBone | NetScientific plc ("NetScientific", the "Group" or the "Company") $1million investment in portfolio company, EpiBone London, UK - 26 November 2021- NetScientific plc (AIM: NSCI), the international life sciences... |
Show more